Medical Care Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Seeks First Volunteer Cohorts for Human-Submitted Image Dataset Testing

Google unveiled new tensor processing units, with J.P. Morgan noting Broadcom's continued role. Broadcom's stock rose 2.5% on Tuesday.

Raymond James reiterated an Outperform rating and $11 price target for Black Diamond Therapeutics (BDTX), citing positive Phase 2 trial data for silevertinib in non-small cell lung cancer. The stock is near its 52-week low of $1.60. The FDA has provided feedback on the Phase 3 trial design, and the company reported Q3 2026 earnings. Stifel raised its price target to $14, maintaining a Buy rating.

Goldman Sachs believes the semiconductor selloff has been excessive, highlighting Nvidia (NVDA), Broadcom (AVGO), and AMD (AMD) as attractive investment opportunities. The firm notes that these stocks are now in oversold territory, with compelling valuations even under pessimistic scenarios. The call comes after a significant market downturn, with the Philadelphia Semiconductor Index down 21% over the past month.

Regeneron Pharmaceuticals reported that its liver drug candidate reduced liver fat by up to 80% in early trials. The company cautioned that further studies are needed to confirm clinical benefits. Regeneron is exploring non-invasive measures for liver disease assessment and has identified genetic factors linked to lower liver disease risk. The company estimates the U.S. MASH market at $1 billion, potentially growing to $15 billion by 2035.

Xilio Therapeutics (XLO) dosed the first patient in its Phase 1/2 trial for XTX501, a cancer treatment, with data expected in Q4 2027. Q3 2026 revenue fell to $10M from $19.1M YoY, while net loss narrowed to $5.9M. The company has $122.2M in cash and expects funding into Q1 2028.

Alphabet's Google introduced two new Tensor Processing Unit (TPU) variants, the 8tx and 8i Max, tailored for specific enterprise needs. The 8tx focuses on secure computing for regulated industries, while the 8i Max supports AI tasks requiring large data context. These chips aim to reduce Google's reliance on external GPUs. Alphabet's shares rose over 2% in premarket trading, despite a 9% decline year-to-date, according to Bloomberg.